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ABSTRACT
Anti N-methyl-D-aspartate receptor (NMDA)receptor encephalitis is one of the most common type of auto immune
encephalitis. Its diagnosis is often delayed due to initial clinical presentation with psychiatric clinical features. Initial
clinical features resemble those of acute psychosis or depression which later evolve into frank neurological
dysfunction. This was first described in association with ovarian teratoma, but it was later also found to exist without
neoplastic association and in men as well. It occurs more frequently in younger age group, mostly below 50 years of
age. Diagnosis is established with the help of cerebrospinal fluid (CSF) analysis for oligo clonal bands and presence of
Anti NMDA receptor antibodies in serum or CSF. CSF assay for antibody is more sensitive compared to serum. This
case report is of a young girl who initially presented with behavioral abnormalities to a psychiatry outpatient and was
later diagnosed with anti NMDA receptor encephalitis after she developed seizures.
KEYWORDS: N-methyl-D-aspartate receptor encephalitis, encephalitis, neuropsychiatry, case report, encephalitis,
NMDA, Anti NMDA receptor encephalitis.
INTRODUCTION
AntiN-methyl D-aspartate (NMDA) receptor encephalitis
was first described in 2007 in association with
teratoma of ovaries in women.1It was later discovered
that anti NMDA receptor encephalitis can occur without
association with cancer as a primary autoimmune
disorder and can occur in men and women of all age
groups.2 However, it is more common in younger age
groups and women.3,4

cause significant morbidity and mortality.6 A study
published by Herken and Pruss7 has included a list of
Red flag signs and milder “yellow flag” signs that
suggest presence of anti NMDA receptor encephalitis in
a patient. “Yellow flag” signs include decreasing
consciousness, catatonia, abnormal movements, focal
signs. Red flag signs include CSF and neuroimaging
abnormalities, Faciobrachial movements, Generalized
seizures, and abnormal movements.

Anti NMDA receptor encephalitis occurs due to
autoimmunity against NR1 subunit of the NMDA
receptor. There exists a significant overlap between
early symptoms of anti NMDA receptor encephalitis and
psychiatric disorders, currently, the understanding of
symptomatology of anti NMDA receptor encephalitis
follows a multiphase model that includes a prodromal
phase of flu like illness followed by phase of psychiatric
manifestations that includes paranoia, depression,
agitation, irritability, aggression and hallucinations. The
psychiatric phase is followed by a phase of frank
neurological dysfunction; this phase is heralded by
presence of clinical signs such as catatonia,seizures,
decreasing conscious level, coma and a variety of
movement disorders.5 A significant percentage of
patients may also develop autonomic instability causing
heart rate and blood pressure abnormalities and may

Our case reports detail a young girl who initially
presented with behavioral abnormalities and was later
diagnosed with anti NMDA receptor encephalitis.
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CASE PRESENTATION:
Patient is a 14 years old girl who first presented
withcomplaints of crying episodes and insomnia.
Patient
had
recently
resumed
school
afterayearlongphysical absence from school due to
COVID-19 pandemic and history suggested presence of
stress due to school and from teachers of student. She
was started on low dose anti-depressant medications.
She presented a few days later to Emergency
department when her behavioural abnormalities had
become considerably worse and she had complaints of
worsening insomnia,hyper religiousness, extreme
feelings of guilt and self-harm. She had no past history

23

VOL. 16 (2) APRIL-JUNE 2021

or family history of psychiatric illness or substance
abuse. Patient was admitted and she gradually became
catatonic over the next three days despite treatment
with anti-depressants and antipsychotics. New onset
abnormal movements of her lips and chewing were
observed one day after admission which resulted in lip
and tongue biting. On the second day of admission
patient developed two episodes of generalized tonic
clonic seizures. Patient was started on antiepileptic
medication along with antibiotics and anti-viral drugs
and workup for possible encephalitis was started. The
patient at that time was catatonic with rigidity and
abnormal posturing of body. Patient’s labs showed
normal blood counts and chemistries with moderate
elevation of CPK which was tested after the generalized
tonic clonic seizure.

A and B showhigh signal foci in bifrontal and parietal
region in white matter and grey-white matter junction.
Patient’s CSF for autoimmune encephalitis antibody
panel was sent at the same time as other investigations
and was reported three days later with a positive titre of
anti NMDA receptor antibodies, at the same time her
HSV PCR was reported as negative. Patients antiviral
and meningitis antibiotic cover was stopped. Patient
was started on IV methylprednisolone one gram daily
for 5 days followed by 5 cycles of alternate day plasma
exchanges
started
5
days
after
stopping
methylprednisolone because patient had mild
improvement of symptoms, her conscious level was still
low and she continued having seizures. Screening for
aetiology of anti NMDA receptor encephalitis was done
including CT scan of chest, abdomen and pelvis and
Antinuclear Antibody testing, both of which came out
negative. Patient was discharged on oral steroids and
antiepileptic medications as her condition started to
improve. On discharge the patient was fully conscious
and takin orally but still had deficits in attention and
memory and calculation. Patient was called for follow
up in opd to access improvement and need for on going
immuno suppression.

Patient’s routine analysis, Culture and HSV PCR was all
normal, making the chances of an infectious
encephalitis low(Table 1).

DISCUSSION:
Case reports of patients with symptoms that were later
ascribed to anti NMDA encephalitis were published in
1997 and 2005 in females and then the symptoms in
all these cases resolved with removal of tumors.8 It was
postulated in these case reports that the symptoms
could be the result of a neoplasm associated vasculitis
which was confirmed in 2007 by Dalmau and
colleagues who published a case series of 12 patients
who had antibodies to NMDA receptors on the surface
of hippocampal neurons. 11 of the these patients had
ovarian teratomas and improved after removal of
tumour. To date over a 1000 cases have been
published, It was discovered that anti NMDA receptor
encephalitis can occur without association with cancer;
as a primary autoimmune disorder and even though all
age
groups
and
genders
have
been
implicated;published data shows that 80% of the
patients were women and less than 50 years of age
with a median age of 21.2,10Anti NMDA receptor
encephalitis is now considered to be the second most
common cause of autoimmune encephalitis after acute
disseminated encephalomyelitis (ADEM). Majority of
patients report a flu like prodromal illness with low
grade fever, nausea, headache, myalgias, and fatigue.
This is followed by development of psychiatric
symptoms
including
delusions,
hallucinations,
paranoia, depression and self-harm.3 Most patients

Patient underwent an MRI of the brain which showed
few small non-specific hyperintense foci on FLAIR and
T2WI in frontal and fronto-parietal areas without any
contrast enhancement or diffusion restriction (Figure
1). These foci were located in white matter and
grey-white matter junction.
A

B

Figure 1. MRI brain plain. T2 weighted (A) and FLAIR (B)
axial images.
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Ovarian teratomas where identified should be removed
and their removal is associated with improvement in
patient symptoms. Some patients with autoimmune
anti NMDA receptor encephalitis may require use of
second line immunotherapy with Cyclophosphamide or
Rituximab.6 A surveillance for ovarian teratomas should
be done for 2 years for patients who have initially tested
negative for ovarian malignancy.

present at this stage of illness and can be mistaken for
acute psychosis and/or substance abuse. In general,
the patients with anti NMDA receptor encephalitis are
less responsive to anti-depressant and anti-psychotic
medication for above symptoms compared to those
with primary psychiatric diagnoses.6 The psychiatric
symptoms evolve over days into catatonia, it is at this
stage that the illness can mimic a neuroleptic
malignant syndrome secondary to use of antipsychotic
drugs. Majority of patients eventually go on to develop
generalized seizures, prompting a neurological
evaluation and an investigation for a possible
encephalitis ensues.12 Abnormal facial and arm
movements are present in a variable number of
patients and when present are an early red flag sign to
direct attention towards diagnosis of autoimmune
encephalitis even before the onset of catatonia and
seizures.

The mortality rate for acute encephalitis is around 4%,
up to75% recover completely while the remaining have
some neurological disability.11. Relapses are more
common in those without teratomas. Predictors of good
outcome include shorter time to diagnosisand timely
initiation of treatment, admission not requiring ICU
care, and less severe symptoms.
CONCLUSION:
Anti NMDA receptor encephalitis is an increasingly
diagnosed cause of encephalitis associated with
psychiatric and neurological manifestations that can be
associated with malignancies. Because of nonspecific
symptoms and overlapping symptoms with other
diseases in early stages delay in diagnosis and
treatment is common and can lead to permanent
neurological deficits and even death. Awareness
regarding its symptoms and signs among clinicians
overall and neurologists specifically can lead to earlier
diagnosis with the help of neuroimaging and CSF
analysis for antibodies with proceeding early treatment
leading to better outcomes. The better outcomes are
more emphasized because a significant cohort of anti
NMDA receptor encephalitis patients are young and
neurological deficits can lead to lifelong disability.

CSF analysis is the cornerstone of diagnosis of anti
NMDA receptor encephalitis. CSF routine analysis can
show mild pleocytosis and protein elevation.
Oligoclonal bands can be present in CSF. CSF analysis
for anti NMDA receptor antibody is confirmatory of
diagnosis, the antibody can be found in serum but is
less sensitive than CSF assay.11 All patients diagnosed
should undergo investigations for presence of tumour
such as an ovarian teratoma. This can be done with CT
scans of chest and abdomen and pelvis or ultrasound
and tumour markers.
Treatment consists of steroids followed by
immunotherapy with IVIG or plasma exchanges. IVIG is
preferred in younger age group and those who have
autonomic disturbances causing hemodynamic
compromise during plasma exchange procedures.
REFERENCES:
1. Dalmau J, Tüzün E, Wu HY, Masjuan J, Rossi JE,
Voloschin A, Baehring JM, Shimazaki H, Koide R,
King D, Mason W. Paraneoplastic
anti–N-methyl-D-aspartate receptor encephalitis
associated with ovarian teratoma. Annals of
neurology. 2007 Jan;61(1):25-36.
2. Dalmau J, Rosenfeld MR, DeAngelis LM, Eichler
AF. Paraneoplastic and autoimmune encephalitis.
UpToDate. 2017.
3. Dalmau J, Lancaster E, Martinez-Hernandez E,
Rosenfeld MR, Balice-Gordon R. Clinical
experience and laboratory investigations in patients
with anti-NMDAR encephalitis. The Lancet
Neurology. 2011 Jan 1;10(1):63-74.
4. Ford B, McDonald A, Srinivasan S. Anti-NMDA

PAKISTAN JOURNAL OF NEUROLOGICAL SCIENCES

receptor encephalitis: a case study and illness
overview. Drugs in context. 2019;8.
5. Wandinger KP, Saschenbrecker S, Stoecker W,
Dalmau J. Anti-NMDA-receptor encephalitis: a
severe, multistage, treatable disorder presenting
with psychosis. Journal of neuroimmunology.
2011 Feb 1;231(1-2):86-91.
6. Kuppuswamy PS, Takala CR, Sola CL.
Management of psychiatric symptoms in
anti-NMDAR encephalitis: a case series,
literature review and future directions.
General hospital psychiatry.
2014 Jul 1;36(4):388-91.
7. Herken J, Prüss H. Red flags: clinical signs f
or identifying autoimmune encephalitis in
psychiatric patients. Frontiers in psychiatry. 2017

25

VOL. 16 (2) APRIL-JUNE 2021

Feb 16;8:25.
8. Vitaliani R, Mason W, Ances B, Zwerdling T, Jiang Z,
Dalmau J. Paraneoplastic encephalitis, psychiatric
symptoms, and hypoventilation in ovarian
teratoma. Annals of Neurology: Official Journal
of the American Neurological Association and the
Child Neurology Society. 2005 Oct;58(4):594-604.
9. Granerod J, Ambrose HE, Davies NW, Clewley JP,
Walsh AL, Morgan D, Cunningham R, Zuckerman
M, Mutton KJ, Solomon T, Ward KN. Causes of
encephalitis and differences in their clinical
presentations in England: a multicentre,
population-based prospective study. The Lancet
infectious diseases. 2010 Dec 1;10(12):835-44.
10.Titulaer MJ, McCracken L, Gabilondo I, Armangué
T, Glaser C, Iizuka T, Honig LS, Benseler SM,

Kawachi I, Martinez-Hernandez E, Aguilar E.
Treatment and prognostic factors for long-term
outcome in patients with anti-NMDA receptor
encephalitis: an observational cohort study. The
Lancet Neurology. 2013 Feb 1;12(2):157-65.
11.Barry H, Byrne S, Barrett E, Murphy KC, Cotter
DR. Anti-N-methyl-d-aspartate
receptor encephalitis: review of clinical
presentation, diagnosis and treatment. BJPsych
Bulletin. 2015 Feb;39(1):19-23.
12.Wong D, Fries B. Anti-NMDAR encephalitis, a
mimicker of acute infectious encephalitis and a
review of the literature. IDCases.
2014 Jan 1;1(4):66-7.

Conflict of interest: Author declares no conflict of interest.
Funding disclosure: Nil
Author’s contribution:
Zaid waqar; data collection, data analysis, manuscript writing, manuscript review
Haris Majid Rajput; concept, data analysis, manuscript writing, manuscript review
Muhammad hassan; data collection, data analysis, manuscript review
Iqra ather; data collection, data analysis, manuscript review
Neelam Naz khattack; data collection, data analysis, manuscript review
Mazhar Badshah; data collection, data analysis, manuscript review

PAKISTAN JOURNAL OF NEUROLOGICAL SCIENCES

26

VOL. 16 (2) APRIL-JUNE 2021

